![Centennial Logo](https://100.scripps.edu/wp-content/uploads/2023/11/centennial-logo.png)
Drug Discovery
An Engine for New Medicines
The Calibr-Skaggs Institute for Innovative Medicines, a nonprofit research institute founded by Scripps Research President and CEO Peter Schultz, joined Scripps Research in 2018 as its drug discovery division.
As a world-class nonprofit “bench to bedside” drug discovery engine, Calibr delivers groundbreaking solutions to unmet medical needs by uniting the creativity of fundamental discovery with highly focused R&D capabilities and expertise.
![Scripps Research Drug Discovery](https://100.scripps.edu/wp-content/uploads/2023/12/scripps-research-drug-discovery.jpg)